Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000525619 | SCV000629328 | benign | Retinoblastoma | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000568188 | SCV000674704 | likely benign | Hereditary cancer-predisposing syndrome | 2018-12-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Illumina Laboratory Services, |
RCV000525619 | SCV001271620 | benign | Retinoblastoma | 2017-09-20 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Institute of Human Genetics, |
RCV001262454 | SCV001440336 | uncertain significance | Ovarian neoplasm | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000568188 | SCV002530847 | benign | Hereditary cancer-predisposing syndrome | 2021-01-13 | criteria provided, single submitter | curation |